NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Characterization of Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

NCT07767448

Not Yet RecruitingNA

Sponsor: Stanford University

Conditions: Cancer

Interventions: La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash, La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream, La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+)

Countries: United States

The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is: Does cosmeceutical topical moisturizers help with skin dryness? Participants will: * Visit the clinic for a baseline visit to complete skin evaluation and tests. * Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit. * Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Adult patient (18 years or older).
* Patients diagnosed with cancer.
* Patient receiving cancer treatment or therapy (receiving chemotherapy, targeted treatment, hormonal therapy, and/or immune checkpoint inhibitors).
* Patient experiencing a dermatological adverse event from a cancer treatment or therapy.

Exclusion Criteria:

* Patient is unable to understand scope of the study.
* Patient is unable to provide written informed consent.
* Patient is healthy.

Locations (1)

Palo Alto, California, United States